ID   KP-2N
AC   CVCL_0U12
DR   cancercelllines; CVCL_0U12
DR   Cosmic; 1122346
DR   Cosmic; 1518238
DR   Wikidata; Q54900361
RX   PubMed=2172194;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 6770; SMAD4; Simple; p.Asp415Glufs*20 (c.1245_1248delCAGA); ClinVar=VCV000142253; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Ala161Asp (c.482C>A); ClinVar=VCV000422295; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C3850; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3004 ! KP-2
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 10
//
RX   PubMed=2172194; DOI=10.1111/j.1349-7006.1990.tb03336.x;
RA   Ikeda Y., Ezaki M., Hayashi I., Yasuda D., Nakayama K., Kono A.;
RT   "Establishment and characterization of human pancreatic cancer cell
RT   lines in tissue culture and in nude mice.";
RL   Jpn. J. Cancer Res. 81:987-993(1990).
//